UnknownPhase 4

Comparison of Remimazolam and Propofol Combination vs. Propofol in IOM

56 participantsStarted 2024-05

Plain-language summary

This study aims to compare total intravenous anesthetic agents: combined remimazolam and propofol vs. propofol monotherapy. The comparison parameters are intraoperative hypotension, patient's involuntary movement, neurophysiological monitoring quality, onset time, recovery time, and postoperative rescue anti-emetics requirements.

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Patients who refuse to participate in the study.
✕. Patients who are pregnant or lactating.
✕. Patients with hypersensitivity to the investigational drugs or to soy, peanuts, or Dextran 40.
✕. Patients with acute narrow-angle glaucoma.
✕. Patients with alcohol or drug dependence.
✕. Patients with hepatic impairment classified as Child-Pugh class C.
✕. Patients with lactose intolerance.
✕. Patients requiring emergency surgery.

What they're measuring

Incidence of intraoperative hypotension

Timeframe: operation day - postoperative 1 day

Trial details

NCT IDNCT06382467

SponsorChung-Ang University Gwangmyeong Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05

Contact for this trial

Jiwon Han, Pf.

821034471988 yesuroon@gmail.com

View on ClinicalTrials.gov More Neurologic Disorder trials